Literature DB >> 21995176

Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow-up, and special situations.

T Caballero1, M L Baeza, R Cabañas, A Campos, S Cimbollek, C Gómez-Traseira, T González-Quevedo, M Guilarte, J Jurado-Palomo, J I Larco, M C López-Serrano, M López-Trascasa, C Marcos, J M Muñoz-Caro, M Pedrosa, N Prior, M Rubio, A Sala-Cunill.   

Abstract

BACKGROUND: There are no previous Spanish guidelines or consensus statements on bradykinin-induced angioedema. AIM: To draft a consensus statement on the management and treatment of angioedema mediated by bradykinin in light of currently available scientific evidence and the experience of experts. This statement will serve as a guideline to health professionals.
METHODS: The consensus was led by the Spanish Study Group on Bradykinin-Induced Angioedema, a working group of the Spanish Society of Allergology and Clinical Immunology. A review was conducted of scientific papers on different types of bradykinin-induced angioedema (hereditary and acquired angioedema due to C1 inhibitor deficiency, hereditary angioedema related to estrogens, angioedema induced by angiotensin-converting enzyme inhibitors). Several discussion meetings were held to reach the consensus.
RESULTS: Treatment approaches are discussed, and the consensus reached is described. Specific situations are addressed, namely, pregnancy, contraception, travelling, blood donation, and organ transplantation.
CONCLUSIONS: A review of and consensus on treatment of bradykinin-induced angioedema is presented.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21995176

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


  22 in total

1.  First Analysis of SERPING1 Gene in Patients with Hereditary Angioedema in Colombia Reveals Two Genotypic Variants in a Highly Symptomatic Individual.

Authors:  Jairo A Rodríguez; Carlos F Narváez
Journal:  J Clin Immunol       Date:  2018-04-05       Impact factor: 8.317

Review 2.  ACE Inhibitor-Induced Angioedema: a Review.

Authors:  William J Kostis; Mrinali Shetty; Yuvraj Singh Chowdhury; John B Kostis
Journal:  Curr Hypertens Rep       Date:  2018-06-08       Impact factor: 5.369

3.  Experimental protocol of dental procedures In patients with hereditary angioedema: the role of anxiety and the use of nitrogen oxide.

Authors:  A Rosa; M Miranda; R Franco; M G Guarino; A Barlattani; P Bollero
Journal:  Oral Implantol (Rome)       Date:  2016-11-13

4.  Drug-induced angioedema: experience of Italian emergency departments.

Authors:  G Bertazzoni; M T Spina; M G Scarpellini; F Buccelletti; M De Simone; M Gregori; V Valeriano; F R Pugliese; M P Ruggieri; M Magnanti; B Susi; L Minetola; L Zulli; F D'Ambrogio
Journal:  Intern Emerg Med       Date:  2013-11-09       Impact factor: 3.397

Review 5.  Review of Select Practice Parameters, Evidence-Based Treatment Algorithms, and International Guidelines for Hereditary Angioedema.

Authors:  Jaison Jose; Jamie Zacharias; Timothy Craig
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

Review 6.  Efficacy assessments in randomized controlled studies of acute therapy for hereditary angioedema.

Authors:  Teresa Caballero
Journal:  J Clin Immunol       Date:  2012-07-15       Impact factor: 8.317

7.  An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II.

Authors:  Bernard Floccard; Etienne Hautin; Laurence Bouillet; Brigitte Coppere; Bernard Allaouchiche
Journal:  Core Evid       Date:  2012-09-27

8.  Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-QoL): Spanish multi-centre research project.

Authors:  Nieves Prior; Eduardo Remor; Carmen Gómez-Traseira; Concepción López-Serrano; Rosario Cabañas; Javier Contreras; Ángel Campos; Victoria Cardona; Stefan Cimbollek; Teresa González-Quevedo; Mar Guilarte; Dolores Hernández Fernández de Rojas; Carmen Marcos; María Rubio; Miguel Ángel Tejedor-Alonso; Teresa Caballero
Journal:  Health Qual Life Outcomes       Date:  2012-07-20       Impact factor: 3.186

9.  WAO Guideline for the Management of Hereditary Angioedema.

Authors:  Timothy Craig; Emel Aygören-Pürsün; Konrad Bork; Tom Bowen; Henrik Boysen; Henriette Farkas; Anete Grumach; Constance H Katelaris; Richard Lockey; Hilary Longhurst; William Lumry; Markus Magerl; Immaculada Martinez-Saguer; Bruce Ritchie; Alexander Nast; Ruby Pawankar; Bruce Zuraw; Marcus Maurer
Journal:  World Allergy Organ J       Date:  2012-12       Impact factor: 4.084

10.  Social costs of icatibant self-administration vs. health professional-administration in the treatment of hereditary angioedema in Spain.

Authors:  Antonio J Blasco; Pablo Lázaro; Teresa Caballero; Mar Guilarte
Journal:  Health Econ Rev       Date:  2013-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.